ArticleJournal of nanobiotechnology2026

A PEGylated nanobody against HBsAg exhibits pleiotropic antiviral efficacy in hepatitis B models.

Qun Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.